The Research Center for Alcoholic Liver and Pancreatic Diseases is the first and only Los Angeles city-wide Research Center of Excellence devoted to """"""""Elucidation of the mechanisms by which ethanol primes and sensitizes the liver and pancreas for injury"""""""". Since its inception in 1999, it has increased the member roster from 9 to 32 and has directly contributed to a growth of NIAAA/NIH-funded alcohol research among the center members to total annual direct costs in excess of $3.4 million. In addition, the Center has achieved new and interactive programmatic developments in undergraduate/graduate/postdoctoral education and training, non-parenchymal liver cell isolation core, cirrhosis research program, epidemiology and prevention program, clinical research, and public outreach program, and this is the basis for the current proposal for a comprehensive research center. Our Center is unique in supporting two distinct basic science approaches. One is addition and deletion analysis for genetic understanding of predisposition to alcoholic liver and pancreatic diseases (ALPD), the approach that is facilitated by the use of the mouse intragastric ethanol infusion model provided by the Center's Animal Core. Another is cell-type specific research to support delineation of the priming and sensitizing mechanisms in each parenchymal and non-parenchymal liver cell types and understanding of complex cellular cross talks that are central to evolution of ALPD. This is supported by the Center's Non-Parenchymal Liver Cell Core separately funded by a NIAAA R24 grant and effective collaborations with the NIDDK-supported USC Liver Center's Cell Culture Core. Further, our Center takes a pride in having these two powerful but technically challenging approaches available to alcohol researchers across the nation via their utilization of the Animal and Non-Parenchymal Liver Cell Cores. The Center is also committed to disseminating new information generated from basic, epidemiological, and clinical research and to developing and implementing educational prevention programs for alcoholic liver disease. These programs are specifically tailored for and targeted to identified high risk groups in our community that incur the most serious medical and socioeconomic impacts from the disease. It is our Center's ultimate goal to promote cutting-edge science on the predisposition mechanisms, to bridge it to the bedside and people in the community, and to help combat the diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Specialized Center (P50)
Project #
5P50AA011999-07
Application #
6877027
Study Section
Special Emphasis Panel (ZAA1-AA (05))
Program Officer
Purohit, Vishnu
Project Start
1999-01-01
Project End
2008-12-31
Budget Start
2005-01-01
Budget End
2005-12-31
Support Year
7
Fiscal Year
2005
Total Cost
$1,625,998
Indirect Cost
Name
University of Southern California
Department
Pathology
Type
Schools of Medicine
DUNS #
072933393
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Waldron, Richard T; Su, Hsin-Yuan; Piplani, Honit et al. (2018) Ethanol Induced Disordering of Pancreatic Acinar Cell Endoplasmic Reticulum: An ER Stress/Defective Unfolded Protein Response Model. Cell Mol Gastroenterol Hepatol 5:479-497
Waldron, Richard T; Lugea, Aurelia; Gulla, Aiste et al. (2018) Proteomic Identification of Novel Plasma Biomarkers and Pathobiologic Pathways in Alcoholic Acute Pancreatitis. Front Physiol 9:1215
Wu, Raymond; Murali, Ramachandran; Kabe, Yasuaki et al. (2018) Baicalein Targets GTPase-Mediated Autophagy to Eliminate Liver Tumor-Initiating Stem Cell-Like Cells Resistant to mTORC1 Inhibition. Hepatology 68:1726-1740
Buxbaum, James; Quezada, Michael; Chong, Bradford et al. (2018) The Pancreatitis Activity Scoring System predicts clinical outcomes in acute pancreatitis: findings from a prospective cohort study. Am J Gastroenterol 113:755-764
Zhao, Qinglan; Wei, Yi; Pandol, Stephen J et al. (2018) STING Signaling Promotes Inflammation in Experimental Acute Pancreatitis. Gastroenterology 154:1822-1835.e2
Edderkaoui, Mouad; Chheda, Chintan; Soufi, Badr et al. (2018) An Inhibitor of GSK3B and HDACs Kills Pancreatic Cancer Cells and Slows Pancreatic Tumor Growth and Metastasis in Mice. Gastroenterology 155:1985-1998.e5
Khanova, Elena; Wu, Raymond; Wang, Wen et al. (2018) Pyroptosis by caspase11/4-gasdermin-D pathway in alcoholic hepatitis in mice and patients. Hepatology 67:1737-1753
Zheng, Han; You, Yang; Hua, Meiyun et al. (2018) Chlorophyllin Modulates Gut Microbiota and Inhibits Intestinal Inflammation to Ameliorate Hepatic Fibrosis in Mice. Front Physiol 9:1671
Lew, Daniel; Wu, Bechien U; Pandol, Stephen J et al. (2018) Disease Course Differences in Acute Pancreatitis Based on Etiology Using the Pancreatitis Activity Scoring System. Pancreas 47:e40-e41
Ogawa, Tomohiro; Li, Yuchang; Lua, Ingrid et al. (2018) Isolation of a unique hepatic stellate cell population expressing integrin ?8 from embryonic mouse livers. Dev Dyn 247:867-881

Showing the most recent 10 out of 415 publications